CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+14.98%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$787M
AUM Growth
+$787M
(+53%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
29.03%
Top 10 Holdings %
Top 10 Hldgs %
30.43%
Holding
459
New
34
Increased
332
Reduced
39
Closed
19
Top Buys
| 1 |
Microsoft
MSFT
|
$18.2M |
| 2 |
NVIDIA
NVDA
|
$11.9M |
| 3 |
Netflix
NFLX
|
$9.94M |
| 4 |
Amazon
AMZN
|
$7.89M |
| 5 |
Meta Platforms (Facebook)
META
|
$7.84M |
Top Sells
| 1 |
Vanguard World Funds Extended Duration ETF
EDV
|
$3.64M |
| 2 |
Alibaba
BABA
|
$2.59M |
| 3 |
XYZ
Block, Inc.
XYZ
|
$2.4M |
| 4 |
Intel
INTC
|
$2.07M |
| 5 |
Coca-Cola
KO
|
$1.91M |
Sector Composition
| 1 | Technology | 37.36% |
| 2 | Healthcare | 29.98% |
| 3 | Consumer Discretionary | 13.6% |
| 4 | Communication Services | 8.97% |
| 5 | Financials | 3.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Texas Instruments
TXN
$184B
| $1.03M | 0.13% |
5,924
+4,113
| +227% | +$717K |
|
127
Revolution Medicines
RVMD
$7.1B
| $1.02M | 0.13% |
31,637
+12,696
| +67% | +$409K |
|
128
Monolithic Power Systems
MPWR
$40B
| $1.02M | 0.13% |
1,500
-1,400
| -48% | -$950K |
|
129
Madrigal Pharmaceuticals
MDGL
$9.76B
| $1.02M | 0.13% |
3,801
+1,509
| +66% | +$403K |
|
130
Halozyme
HALO
$8.56B
| $990K | 0.13% |
24,348
-29,733
| -55% | -$1.21M |
|
131
Krystal Biotech
KRYS
$4.27B
| $972K | 0.12% |
5,463
+2,204
| +68% | +$392K |
|
132
Fortinet
FTNT
$60.4B
| $952K | 0.12% |
13,942
-26,086
| -65% | -$1.78M |
|
133
Exxon Mobil
XOM
$487B
| $933K | 0.12% |
+8,025
| New | +$933K |
|
134
Li Auto
LI
$23.7B
| $914K | 0.12% |
30,200
-7,800
| -21% | -$236K |
|
135
Immunovant
IMVT
$2.56B
| $903K | 0.11% |
27,936
+11,202
| +67% | +$362K |
|
136
T-Mobile US
TMUS
$284B
| $874K | 0.11% |
5,353
+3,039
| +131% | +$496K |
|
137
Alkermes
ALKS
$4.78B
| $869K | 0.11% |
32,110
+12,804
| +66% | +$347K |
|
138
Legend Biotech
LEGN
$6.41B
| $858K | 0.11% |
15,292
+6,070
| +66% | +$340K |
|
139
PVH
PVH
$4.05B
| $853K | 0.11% |
+6,063
| New | +$853K |
|
140
Nuvalent
NUVL
$5.52B
| $846K | 0.11% |
11,262
+4,643
| +70% | +$349K |
|
141
Wolfspeed
WOLF
$194M
| $826K | 0.11% |
28,000
-8,353
| -23% | -$246K |
|
142
Expedia Group
EXPE
$26.6B
| $814K | 0.1% |
5,907
+2,577
| +77% | +$355K |
|
143
Iovance Biotherapeutics
IOVA
$807M
| $796K | 0.1% |
53,708
+24,106
| +81% | +$357K |
|
144
Starbucks
SBUX
$100B
| $786K | 0.1% |
8,603
-3,272
| -28% | -$299K |
|
145
Insmed
INSM
$28.8B
| $775K | 0.1% |
28,569
+12,018
| +73% | +$326K |
|
146
Johnson & Johnson
JNJ
$427B
| $765K | 0.1% |
+4,833
| New | +$765K |
|
147
Ultragenyx Pharmaceutical
RARE
$2.89B
| $738K | 0.09% |
15,817
+6,316
| +66% | +$295K |
|
148
Axsome Therapeutics
AXSM
$6.05B
| $726K | 0.09% |
9,103
+3,628
| +66% | +$290K |
|
149
iShares Gold Trust Micro
IAUM
$3.48B
| $709K | 0.09% |
32,000
+1,000
| +3% | +$22.2K |
|
150
Arcellx
ACLX
$3.85B
| $708K | 0.09% |
10,177
+4,545
| +81% | +$316K |
|